This book will be sought out by women wishing to know more about Evista, Eli Lilly's trade name for raloxifene, which received FDA approval in January 1998 for the prevention of osteoporosis. Goldstein, a member of the advisory board for the team that developed raloxifene, and Ashner, a journalist and therapist, provide help in assessing the benefits and side effects of this new therapy, which benefits bones and lipid profile while significantly reducing the risk of breast cancer linked to traditional hormone replacement therapy (HRT). The authors emphasize that raloxifene and other SERMs (estrogen substitutes) are approved for use by postmenopausal women. HRT remains the treatment of choice for hot flashes and other symptoms experienced during menopause; postmenopausal women can benefit from raloxifene, which acts like estrogen in the bones and cardiovascular tissues but not in the reproductive system. For those who choose not to take estrogens during menopause, the authors offer suggestions for coping with symptoms. Recommended.?Jodith Janes, Cleveland Clinic Foundation
Copyright 1998 Reed Business Information, Inc. --This text refers to an out of print or unavailable edition of this title.
Book Description
A reader-friendly guide to Hormone Replacement Therapy and the first book to feature SERMs, the new estrogen substitutes....Now women can enjoy the many benefits of estrogen--without all the worry.
"A new alternative to estrogen may offer older women many of the hormone's heart-and-bone-protecting advantages without one of its most worrisome side effects--the increased risk of breast cancer."
--Associated Press
Every postmenopausal woman must face the estrogen dilemma. Replacing estrogen lowers the incidence of heart disease, osteoporosis, and Alzheimer's disease--but it also increases the chance of breast and uterine cancer. Until now...New synthetic hormones, SERMs, provide many of the benefits of estrogen without the risks. Written by Steven R. Goldstein, M.D., a world-renowned obstetrician and gynecologist, and Laurie Ashner, a prominent journalist and therapist, The Estrogen Alternative is the first book to reveal the latest advances in the field. This essential and accessible guide--updated with new material for the paperback edition--answers important questions about traditional estrogen therapy, herbal estrogen therapy and SERMs, as well as which form of hormone replacement therapy is best for one's individual needs.
* Includes new, updated material, featuring the latest advances in the field
* The estrogen dilemma is one of the most important concerns for postmenopausal women
* Author Steven Goldstein, M.D., was on the advisory committee to the team that developed Raloxifene, and has lectured to one out of three OB/GYNs in the U.S.
See all Editorial Reviews
